Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Provided By GlobeNewswire
Last update: Jul 31, 2025
Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors
Recent Leadership Appointments Bring Deep Experience in Oncology Drug Development, Clinical Operations and Building Biotechnology Companies
Read more at globenewswire.comNASDAQ:CBIO (10/10/2025, 9:14:12 PM)
11.35
-0.92 (-7.5%)
Find more stocks in the Stock Screener
